Key Drivers
- Cash Conversion
- Thin Earnings
- Low Returns
AIAI Summary
ICUI should be viewed less as a headline growth story and more as a portfolio-simplification and margin-rebuild play, where positive free cash flow and improving gross margin support the thesis but durable upside depends on execution in Infusion Systems, regulatory timing on new pumps, and avoiding further Vital Care drag.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Thin Earnings
- •Low Returns
ICUI generates solid cash flow and maintains good liquidity, but weak earnings quality, low capital returns, and a not-cheap valuation temper the investment case.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support holding
- •Bounce failure
ICUI has been in a short-term downtrend over the last month, with lower highs and repeated failures near $123-$126, though $115-$117 support is still holding and a recovery would need to clear $129-$131.
A sharp rebound to $126.43 on 2026-05-08 quickly reversed, showing the bounce lacked follow-through
Sentiment & News
Key News Insights:
- •Earnings beat
- •Pump growth
- •Volatility spike
ICU Medical had a mixed but ultimately constructive week as pre-earnings caution and a stock dip gave way to an earnings beat, product-driven growth optimism, and a post-results volatility spike.
The quarter looks modestly positive for ICUI, but elevated implied volatility shows investors are still waiting for clearer follow-through
Similar Companies in Healthcare
Other companies in the same sector with AI ratings